Overview
A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.
Indication
For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension.
Associated Conditions
- Ocular Hypertension
- Open Angle Glaucoma (OAG)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | 24208-505 | OPHTHALMIC | 5 mg in 1 mL | 10/31/2022 | |
| Physicians Total Care, Inc. | 54868-3363 | OPHTHALMIC | 5 mg in 1 mL | 6/12/2012 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| RATIO-LEVOBUNOLOL | teva canada limited | 02031167 | Solution - Ophthalmic | 0.5 % | 12/31/1995 |
| BETAGAN 0.5% OPHTHALMIC SOL | 00637661 | Liquid - Ophthalmic | 0.5 % | 12/31/1985 | |
| BETAGAN OPH SOLN 0.25% | 00751286 | Liquid - Ophthalmic | 0.25 % | 12/31/1990 | |
| SANDOZ LEVOBUNOLOL | 02241715 | Liquid - Ophthalmic | 0.25 % | 8/21/2000 | |
| NOVO-LEVOBUNOLOL - LIQ 0.25% | novopharm limited | 02197456 | Liquid - Ophthalmic | 0.25 % | 7/30/1996 |
| RATIO-LEVOBUNOLOL | teva canada limited | 02031159 | Solution - Ophthalmic | 0.25 % | 12/31/1995 |
| PMS-LEVOBUNOLOL | 02237990 | Liquid - Ophthalmic | 0.25 % | N/A | |
| LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | bausch & lomb pharmaceuticals inc. | 02231715 | Liquid - Ophthalmic | 0.50 % | 9/4/1997 |
| SANDOZ LEVOBUNOLOL | 02241716 | Liquid - Ophthalmic | 0.5 % | 8/21/2000 | |
| PMS-LEVOBUNOLOL | 02237991 | Liquid - Ophthalmic | 0.5 % | 8/31/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.